Log in

6547 Medigen Vaccine Biologics Corp. TPEX · Taiwan

Medigen Vaccine Biologics (6547) news

Medigen Vaccine Biologics Corp. is a public biotech or pharmaceutical company listed on TPEX under the ticker 6547, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Medigen Vaccine Biologics news

We have not published a story on Medigen Vaccine Biologics yet. When there is news, it will appear here.

Questions about Medigen Vaccine Biologics

What is the ticker symbol of Medigen Vaccine Biologics?

Medigen Vaccine Biologics Corp. trades under the ticker 6547 on TPEX.

Where is Medigen Vaccine Biologics listed?

Medigen Vaccine Biologics Corp. is listed on TPEX.

Which country or territory is Medigen Vaccine Biologics listed under?

Our directory records Medigen Vaccine Biologics Corp. under Taiwan.

What does Medigen Vaccine Biologics do?

Our directory classifies Medigen Vaccine Biologics Corp. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Medigen Vaccine Biologics?

The ISIN recorded for Medigen Vaccine Biologics Corp. is TW0006547003.

Does aibio.space cover Medigen Vaccine Biologics?

aibio.space lists Medigen Vaccine Biologics Corp. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Medigen Vaccine Biologics?

Companies in our directory listed in the same country and business area as Medigen Vaccine Biologics: Caliway Biopharmaceuticals Co, Advanced Biomed, BoYen Therapeutics, RBC Bioscience, LAUNXP BIOMEDICAL CO., LTD., HeXun Biosciences Co.

Investor discussion: Medigen Vaccine Biologics

Members talk about Medigen Vaccine Biologics (6547). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TPEX:6547 on TradingView.

Listing details

Medigen Vaccine Biologics Corp. is a public biotech or pharmaceutical company listed on TPEX under the ticker 6547, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Medigen Vaccine Biologics Corp.
Ticker
6547
Listing
TPEX
Country or territory
Taiwan
Business scope
Biotechnology
ISIN
TW0006547003
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.